4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Psyence Biomedical Ltd. (PBM) operates in the Biotechnology industry and is headquartered in Toronto, Canada with about 12 employees. Its market capitalization is roughly $11 million. In the fiscal year ended 2026-03-31, PBM reported $0M in revenue and ($7M) in net income.
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($4M) | ($43M) | ($3M) | — |
| Net Income | ($7M) | $1M | ($51M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-09-30 |
|---|---|
| Total Revenue | $0M |
| Operating Income (EBIT) | ($2M) |
| Net Income | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | $18M | $7M | $1M | $2M | — |
| Total Liabilities | $1M | $1M | $12M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PBM viewer.
About TickerBase · Data methodology & sources